Who Buys Meloxicam from India — 566 Importers Behind a $199.4M Market
India's meloxicam import market is served by 566 active buyers who collectively imported $199.4M across 3,297 shipments. UNICHEM PHARMACEUTICALS (USA) INC.. (UNITED STATES) leads with a 43.4% market share, followed by UNICHEM PHARMACEUTICALS (USA) INC. and CIPLA USA INC UPS SUPPLY CHAIN SOLU. The top 5 buyers together control 82.7% of total import value, reflecting a concentrated buyer landscape.
Top Meloxicam Importers — Ranked by Import Value
UNICHEM PHARMACEUTICALS (USA) INC.. (UNITED STATES) is the leading meloxicam importer from India, holding a 43.4% share of the $199.4M market across 3,297 shipments from 566 buyers. The top 5 buyers — UNICHEM PHARMACEUTICALS (USA) INC.. (UNITED STATES), UNICHEM PHARMACEUTICALS (USA) INC. (UNITED STATES), CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES), EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), CIPLA USA INC UPS SUPPLY CHAIN SOL (UNITED STATES) — collectively control 82.7% of total import value.
Top Meloxicam Buyers & Importers
Ranked by import value · 566 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | UNICHEM PHARMACEUTICALS (USA) INC..UNITED STATES PHARMA : MELOXICAM 15MG TABLETS - 7308 BTLS X 1000 TABSPHARMA : MELOXICAM 15MG TABLETS - 7164 BTLS X 1000 TABSMELOXICAM TABS USP 15MG NDC NO.6909715907 ANDA NO. 77929 | $86.6M | 5 | 43.4% |
| 2 | UNICHEM PHARMACEUTICALS (USA) INC.UNITED STATES PHARMA : MELOXICAM 15MG TABLETS - 7308 BTLS X 1000 TABSPHARMA : MELOXICAM 15MG TABLETS - 7164 BTLS X 1000 TABSMELOXICAM TABS USP 15MG NDC NO.6909715907 ANDA NO. 77929 | $44.7M | 5 | 22.4% |
| 3 | CIPLA USA INC UPS SUPPLY CHAIN SOLUUNITED STATES PHARMA : MELOXICAM 15MG TABLETS - 7308 BTLS X 1000 TABSPHARMA : MELOXICAM 15MG TABLETS - 7164 BTLS X 1000 TABSMELOXICAM TABS USP 15MG NDC NO.6909715907 ANDA NO. 77929 | $25.3M | 5 | 12.7% |
| 4 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES PHARMA : MELOXICAM 15MG TABLETS - 7308 BTLS X 1000 TABSPHARMA : MELOXICAM 15MG TABLETS - 7164 BTLS X 1000 TABSMELOXICAM TABS USP 15MG NDC NO.6909715907 ANDA NO. 77929 | $6.8M | 5 | 3.4% |
| 5 | CIPLA USA INC UPS SUPPLY CHAIN SOLUNITED STATES PHARMA : MELOXICAM 15MG TABLETS - 7308 BTLS X 1000 TABSPHARMA : MELOXICAM 15MG TABLETS - 7164 BTLS X 1000 TABSMELOXICAM TABS USP 15MG NDC NO.6909715907 ANDA NO. 77929 | $1.5M | 5 | 0.8% |
| 6 | UNICHEM PHARMACEUTICALS USA INCUNITED STATES PHARMA : MELOXICAM 15MG TABLETS - 7308 BTLS X 1000 TABSPHARMA : MELOXICAM 15MG TABLETS - 7164 BTLS X 1000 TABSMELOXICAM TABS USP 15MG NDC NO.6909715907 ANDA NO. 77929 | $1.0M | 5 | 0.5% |
| 7 | GENERIC PARTNERS PTY LTDAUSTRALIA MELOCOX 15MG TABLETS -21049 PAC X 3 X 10 TABSPHARMA : MELOXAN 15MG TABLETS - 4272 PAC X 6 X 10 TABSMELOXICAM SANDOZ 15MG CAPSULES( MELOXICA | $843.8K | 5 | 0.4% |
| 8 | NICHE GENERICS LTD.IRELAND PHARMA : MELOXICAM 15MG TABLETS - 7308 BTLS X 1000 TABSPHARMA : MELOXICAM 15MG TABLETS - 7164 BTLS X 1000 TABSMELOXICAM TABS USP 15MG NDC NO.6909715907 ANDA NO. 77929 | $643.3K | 5 | 0.3% |
| 9 | ALLEGENS COMPANY LIMITEDVIETNAM MELOCAM 7.5 10X10SMOOV 7.5 (EACH FILM COATED TABLET CONTAINS:MELOXICAM B.P. 7.5MG | $563.7K | 5 | 0.3% |
| 10 | SANDOZ PTY LTD,AUSTRALIA MELOXICAM SANDOZ 15MG CAPSULES( MELOXICAMELOXICAM SANDOZ 15 MG TABLET. (INV.QTYMELOXICAM SANDOZ 7.5 MG TABLET (MELOXICA | $479.5K | 5 | 0.2% |
| 11 | EUROFARMA LABORATORIOS SALCNPJBRAZIL MELOCOX ODT 15MG 5CPR AG | $427.8K | 5 | 0.2% |
| 12 | BREATHEFREE LANKA PVT LTDSRI LANKA | $344.0K | 5 | 0.2% |
| 13 | APOTEX PTY LTD.,AUSTRALIA MELOXICAM SANDOZ 15MG CAPSULES( MELOXICAMELOXICAM SANDOZ 15 MG TABLET. (INV.QTYMELOXICAM SANDOZ 7.5 MG TABLET (MELOXICA | $288.3K | 5 | 0.1% |
| 14 | ZENTIVA K.S.CZECH REPUBLIC | $276.1K | 5 | 0.1% |
| 15 | ASCENDERS CONSULTING SERVICES LTDUNITED KINGDOM MELOXICAM 15MG TABLESMELOXICAM 7.5MG TABLESMELOXICAM 7.5MG TABLETS 3X10TNOS | $274.6K | 5 | 0.1% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Meloxicam — and from which countries?
Flow of Meloxicam exports from India: each country's share and the named importers behind the numbers
Meloxicam — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $172.0M through 971 shipments. This represents a market share of 86.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• UNICHEM PHARMACEUTICALS (USA) INC.. - $86.6M (50.3% of country's total business)
• UNICHEM PHARMACEUTICALS (USA) INC. - $44.7M (26.0% of country's total business)
• CIPLA USA INC UPS SUPPLY CHAIN SOLU - $25.3M (14.7% of country's total business)
• EVERSANA LIFE SCIENCE SERVICES - $6.8M (3.9% of country's total business)
• CIPLA USA INC UPS SUPPLY CHAIN SOL - $1.5M (0.9% of country's total business)
• Rest of United States's importers - $7.2M (4.2% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $177.2K, indicating premium pricing strategy compared to the market average of $60.5K.
United States is a key market for Meloxicam imports, representing 86.3% of total trade value.
2Serbia
Serbia emerges as the second largest importing country, achieving a total trade value of $6.0M through 0 shipments. This represents a market share of 3.0% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Serbia demonstrates strong market positioning with an average shipment value of $6.0M, indicating premium pricing strategy compared to the market average of $60.5K.
Serbia is a key market for Meloxicam imports, representing 3.0% of total trade value.
3Australia
Australia emerges as the third largest importing country, achieving a total trade value of $3.1M through 88 shipments. This represents a market share of 1.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• GENERIC PARTNERS PTY LTD - $843.8K (27.2% of country's total business)
• SANDOZ PTY LTD, - $479.5K (15.5% of country's total business)
• APOTEX PTY LTD., - $288.3K (9.3% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $35.2K, indicating competitive pricing strategy compared to the market average of $60.5K.
Australia is a key market for Meloxicam imports, representing 1.6% of total trade value.
4Nigeria
Nigeria emerges as the fourth largest importing country, achieving a total trade value of $2.9M through 0 shipments. This represents a market share of 1.5% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $2.9M, indicating premium pricing strategy compared to the market average of $60.5K.
Nigeria is a key market for Meloxicam imports, representing 1.5% of total trade value.
5Vietnam
Vietnam emerges as the fifth largest importing country, achieving a total trade value of $2.5M through 8 shipments. This represents a market share of 1.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Vietnam has a diverse importer base, with their top importers including:
• ALLEGENS COMPANY LIMITED - $563.7K (22.2% of country's total business)
Key Insight: Vietnam demonstrates strong market positioning with an average shipment value of $317.4K, indicating premium pricing strategy compared to the market average of $60.5K.
Vietnam is a key market for Meloxicam imports, representing 1.3% of total trade value.
Buyer Segment Analysis
TransData Nexus Meloxicam buyer market intelligence
1Buyer Segment Analysis
The importation of Meloxicam from India involves various buyer segments, each with distinct purchasing behaviors:
1. Distributors: Entities like UNICHEM PHARMACEUTICALS (USA) INC. and CIPLA USA INC. fall into this category. They procure large volumes to supply pharmacies, hospitals, and healthcare providers. Their purchasing patterns are characterized by bulk orders and regular shipments to maintain a steady supply chain.
2. Contract Manufacturers: Companies such as EVERSANA LIFE SCIENCE SERVICES may act as contract manufacturers, importing Meloxicam for formulation, packaging, or further processing before distribution. Their procurement is project-based, aligning with production schedules and client demands.
3. Re-exporters: Firms like GENERIC PARTNERS PTY LTD (Australia) and NICHE GENERICS LTD. (Ireland) might import Meloxicam for re-export to other markets. Their buying behavior is influenced by global demand fluctuations and regulatory considerations in target markets.
4. Government Procurement Agencies: Entities such as ALLEGENS COMPANY LIMITED (Vietnam) and SANDOZ PTY LTD (Australia) may engage in government tenders, supplying Meloxicam to public health programs. Their orders are typically large and periodic, corresponding with tender awards and budget cycles.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Meloxicam buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the importation of Meloxicam is governed by the following regulatory frameworks:
1. United States:
2. Serbia:
3. Australia:
4. Nigeria:
5. Vietnam:
Importers should consult the respective regulatory authorities for the most current and detailed requirements, as regulations and tariffs are subject to change.
Demand Drivers & Market Opportunity
TransData Nexus Meloxicam buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Meloxicam in importing countries is influenced by several key factors:
1. Disease Prevalence: Meloxicam is commonly prescribed for managing pain and inflammation associated with conditions like osteoarthritis and rheumatoid arthritis. The prevalence of these chronic conditions is rising globally due to aging populations and lifestyle changes, thereby increasing the demand for effective nonsteroidal anti-inflammatory drugs (NSAIDs) like Meloxicam.
2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding their healthcare programs to provide broader access to essential medicines. For instance, the World Health Organization (WHO) reports that over 150 countries have adopted national essential medicines lists based on the WHO Model List, aiming to improve access to essential medicines and progress towards universal health coverage. (who.int)
3. WHO Essential Medicines List Procurement: The inclusion of Meloxicam in the WHO Model List of Essential Medicines underscores its importance in treating priority health conditions. This inclusion encourages countries to prioritize its procurement and ensures its availability in public health systems. (who.int)
4. Tender-Based Purchasing: Many governments and large healthcare organizations procure medicines through tender processes to ensure cost-effectiveness and supply security. The competitive nature of these tenders can drive demand for Meloxicam, especially when it is included in national formularies and essential medicines lists.
With 566 buyers across 100 countries, the global market for Meloxicam presents significant opportunities. Understanding the specific demand drivers in each market can enable suppliers to tailor their strategies effectively, ensuring they meet the needs of diverse healthcare systems and patient populations.
Common Questions — Meloxicam Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest meloxicam buyer importing from India?
Based on import volume and value, UNICHEM PHARMACEUTICALS (USA) INC.. (UNITED STATES) leads with $86.6M in imports and a 43.4% market share — the highest of any single meloxicam importer. UNICHEM PHARMACEUTICALS (USA) INC. (UNITED STATES) and CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) are the next largest buyers.
QHow many companies buy meloxicam from India?
There are 566 active meloxicam buyers importing from India, with a combined market of $199.4M across 3,297 shipments to 100 countries. The top 5 buyers hold 82.7% of total import value, while the remaining 561 buyers handle the other 17.3%.
QWhich countries import the most meloxicam from India?
The top importing countries for meloxicam from India are United States (86.3%), Serbia (3.0%), Australia (1.6%), Nigeria (1.5%), Vietnam (1.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of meloxicam, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for meloxicam from India?
The average import transaction value for meloxicam from India is $60.5K, with an average unit price of $1.58 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Meloxicam buyer market intelligence
1Buyer Segment Analysis
The importation of Meloxicam from India involves various buyer segments, each with distinct purchasing behaviors:
1. Distributors: Entities like UNICHEM PHARMACEUTICALS (USA) INC. and CIPLA USA INC. fall into this category. They procure large volumes to supply pharmacies, hospitals, and healthcare providers. Their purchasing patterns are characterized by bulk orders and regular shipments to maintain a steady supply chain.
2. Contract Manufacturers: Companies such as EVERSANA LIFE SCIENCE SERVICES may act as contract manufacturers, importing Meloxicam for formulation, packaging, or further processing before distribution. Their procurement is project-based, aligning with production schedules and client demands.
3. Re-exporters: Firms like GENERIC PARTNERS PTY LTD (Australia) and NICHE GENERICS LTD. (Ireland) might import Meloxicam for re-export to other markets. Their buying behavior is influenced by global demand fluctuations and regulatory considerations in target markets.
4. Government Procurement Agencies: Entities such as ALLEGENS COMPANY LIMITED (Vietnam) and SANDOZ PTY LTD (Australia) may engage in government tenders, supplying Meloxicam to public health programs. Their orders are typically large and periodic, corresponding with tender awards and budget cycles.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Meloxicam buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the importation of Meloxicam is governed by the following regulatory frameworks:
1. United States:
2. Serbia:
3. Australia:
4. Nigeria:
5. Vietnam:
Importers should consult the respective regulatory authorities for the most current and detailed requirements, as regulations and tariffs are subject to change.
Demand Drivers & Market Opportunity
TransData Nexus Meloxicam buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Meloxicam in importing countries is influenced by several key factors:
1. Disease Prevalence: Meloxicam is commonly prescribed for managing pain and inflammation associated with conditions like osteoarthritis and rheumatoid arthritis. The prevalence of these chronic conditions is rising globally due to aging populations and lifestyle changes, thereby increasing the demand for effective nonsteroidal anti-inflammatory drugs (NSAIDs) like Meloxicam.
2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding their healthcare programs to provide broader access to essential medicines. For instance, the World Health Organization (WHO) reports that over 150 countries have adopted national essential medicines lists based on the WHO Model List, aiming to improve access to essential medicines and progress towards universal health coverage. (who.int)
3. WHO Essential Medicines List Procurement: The inclusion of Meloxicam in the WHO Model List of Essential Medicines underscores its importance in treating priority health conditions. This inclusion encourages countries to prioritize its procurement and ensures its availability in public health systems. (who.int)
4. Tender-Based Purchasing: Many governments and large healthcare organizations procure medicines through tender processes to ensure cost-effectiveness and supply security. The competitive nature of these tenders can drive demand for Meloxicam, especially when it is included in national formularies and essential medicines lists.
With 566 buyers across 100 countries, the global market for Meloxicam presents significant opportunities. Understanding the specific demand drivers in each market can enable suppliers to tailor their strategies effectively, ensuring they meet the needs of diverse healthcare systems and patient populations.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 566 global importers of Meloxicam identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,297 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 100 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,297 Verified Shipments
566 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists